Latest News

Lake Cumberland Regional Hospital Introduces Aquablation Therapy for the Treatment of BPH

August 11, 2025
aquablation

Lake Cumberland Regional Hospital (LCRH) announced today that it is the first in Pulaski County to offer a new advanced robotic therapy for the treatment of lower urinary tract symptoms (LUTS) due to benign prostatic hyperplasia (BPH).

Aquablation therapy utilizes a surgical robot with automated tissue resection, combining real-time multi-dimensional imaging and heat-free waterjet ablation for precise and controlled removal of prostate tissue.

BPH, an enlarged prostate, is a non-cancerous condition characterized by the prostate growing larger than normal. One in two men aged 51 to 60 experience BPH, with the incidence increasing every decade. If untreated, BPH can lead to significant health issues such as bladder or kidney damage, bladder stones, and urinary difficulties.

Surgeons create a personalized treatment plan by integrating cystoscopic visualization and ultrasound imaging tailored to each patient’s anatomy. Once the mapping is complete, the robotically controlled waterjet ablates the prostate tissue while avoiding critical structures to maintain overall function. Numerous clinical studies have shown that aquablation therapy provides predictable and reproducible outcomes regardless of prostate size or surgeon experience.

Dr. Eric Ruby, urologist at Lake Cumberland Regional Hospital, is the featured physician for this initiative, bringing many years of dedicated service as a practicing urologist in the community while leading the way in this new technology. He states, “Aquablation therapy represents a significant step forward in our ability to address BPH effectively. By safely and precisely targeting the problematic tissue, we can achieve remarkable symptom relief while significantly reducing the risks often associated with traditional surgical methods.”

“We are proud to offer a solution for men with BPH that provides significant long-lasting symptom relief with a lower risk to their overall health,” said Carolyn Sparks, CEO. “This therapy reinforces our commitment to robotic surgery and men’s health.”

Current surgical treatments for BPH often force patients to make challenging decisions; achieving significant symptom relief frequently comes with the risk of severe side effects, while minimizing these risks typically results in limited symptom relief. Patients now have an additional option with aquablation therapy, which provides substantial symptom relief while minimizing the risk of adverse effects. This new therapy enhances the treatment landscape, balancing efficacy and safety and significantly improving overall patient outcomes and quality of life.

For more information about options for BPH or to schedule an appointment with a provider, visit LakeCumberlandHospital.com/urology or call 800.424.DOCS. 

Read All Posts